ArticleFrontiers in immunology2020

Bimekizumab, a Novel Humanized IgG1 Antibody That Neutralizes Both IL-17A and IL-17F.

Ralph Adams et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.